Mo.Salah87

[Abdulrahman Arabi @abdarabi]

🧵 New national study from Qatar 🇶🇦: significant decline in STEMI mortality after PPCI

We analyzed 7,959 STEMI patients undergoing PPCI from 2015–2023 providing one of the largest national datasets from the Middle East.

https://t.co/50K9f4kVwl

[Abdulrahman Arabi @abdarabi]

From forgotten to the forefront — the tricuspid valve takes center stage at #GHA17 in Doha! 💡
Join us to explore the latest updates and innovations in tricuspid valve disease and intervention ❤️🩺
From the world’s leading experts in #TVD and #TTVR 🌍

[Abdulrahman Arabi @abdarabi]

Proud of HMC’s graduates recognized at the Arab Board Forum in Amman! 🎓👏 Fourteen, including three from the Heart Hospital, were honored for excellence in research and education — a testament to HMC’s commitment to excellence.

[Mo.Salah87 @Salah87Mo]

@abdarabi @AlhijjiM @HMC_Qatar Dr. @abdarabi and @AlhijjiM,
We couldn't have achieved this without your invaluable support, mentorship, and guidance. Your contributions have been instrumental in our growth, and we're truly grateful for your mentorship.

[Mohammad AlTermanini @MAltermanini]

🚨 New in JACC: Case Reports!
We are proud to share our case series from Heart Hospital –HMC🇶🇦 on vacuum-assisted aspiration (AngioVac) of intracardiac masses, highlighting its role as a bridge or alternative to surgery in infective endocarditis.
👉 https://t.co/NJUOZ6c6Qm
#JACC

[Pablo Corral MD @drpablocorral]

🙌Game-changing real-world data from SWEDEHEART!

📰Leosdottir et al., JACC 2024 https://t.co/AzeX7q4KlY

Title: Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes

👩‍🦰🧑‍🦰Population: >71,000 post-MI patients on high-intensity statins
Groups:
1️⃣ Ezetimibe within 6 months of MI
2️⃣ Ezetimibe 6–12 months post-MI
3️⃣ No ezetimibe

🤩Findings: Early ezetimibe → ↓ 22% in MACE (HR 0.78 [0.70–0.86]) vs. late initiation
☝️Compared to no ezetimibe → HR 0.85 [0.79–0.91] ☝️NNT = 53 to prevent 1 MACE with early initiation
☝️Mortality also significantly reduced with early use

👉Delaying ezetimibe after MI = missed opportunity to prevent events.

The message is clear: Start combination lipid-lowering therapy early—not when LDLc remains high, but when risk is high.

@society_eas
@ProfKausikRay